Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

BMS-936559

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

BMS

Drug class:

PD-L1 inhibitor

Related drugs:

atezolizumab (236)

durvalumab (200)

benmelstobart (12)

sugemalimab (7)

envafolimab (6)

imsapepimut and etimupepimut, adjuvanted (4)

socazolimab (2)

atezolizumab and hyaluronidase-tqjs (1)

cosibelimab-ipdl (1)

adebrelimab (0)

CF33-hNIS-antiPDL1 (0)

PD-L1.t-haNK (0)

PF-07257876 (0)

Undisclosed anti-PD-L1 antibody (0)

›